<?xml version="1.0" encoding="UTF-8" ?> 

<rss version="2.0"> 
<channel> 
<title>Pharmacology/kinetics News</title> 
<link>http://www.mdlinx.com/NephrologyLinx/news.cfm/newspage/1/spec_id/20/subspec_id/556</link> 
<description>Pharmacology/kinetics</description> 
<language>en-us</language> 
<copyright>Copyright 2009 MDLinx, Inc.</copyright>









<item> 
 <title><![CDATA[Visit www.LIPITORHCP.com for more information, free materials, and helpful resources.]]></title> 
 <link>http://WWW.mdlinx.com/tracking.cfm?campaign_id=1172&amp;redirect=http://www.LIPITORHCP.com</link> 
 <pubDate>1/1/2008</pubDate> 
 <description><![CDATA[<b>Sponsored by LIPITOR (atorvastatin calcium)</b>]]></description> 
 <guid>http://www.LIPITORHCP.com</guid> 
</item>
 



<item> 
<title><![CDATA[Statin Therapy Ameliorates Renal Allograft Function]]></title> 
<link>http://www.mdlinx.com/NephrologyLinx/xml-article.cfm/2982628</link> 
<pubDate>12/18/2009</pubDate> 
<description><![CDATA[<b>Transplantation Proceedings</b>]]></description> 
<guid>http://www.mdlinx.com/NephrologyLinx/xml-article.cfm/2982628</guid>
</item> 
 

<item> 
<title><![CDATA[Efficacy and safety of pazopanib in patients with metastatic renal cell carcinoma ]]></title> 
<link>http://www.mdlinx.com/NephrologyLinx/xml-article.cfm/2987414</link> 
<pubDate>12/18/2009</pubDate> 
<description><![CDATA[<b>Journal of Clinical Oncology</b>]]></description> 
<guid>http://www.mdlinx.com/NephrologyLinx/xml-article.cfm/2987414</guid>
</item> 
 

<item> 
<title><![CDATA[Effects of Cyclosporine-Tacrolimus Switching in Posttransplantation Hyperlipidemia on High-Density Lipoprotein 2/3, Lipoprotein A1/B, and Other Lipid Parameters]]></title> 
<link>http://www.mdlinx.com/NephrologyLinx/xml-article.cfm/2982629</link> 
<pubDate>12/18/2009</pubDate> 
<description><![CDATA[<b>Transplantation Proceedings</b>]]></description> 
<guid>http://www.mdlinx.com/NephrologyLinx/xml-article.cfm/2982629</guid>
</item> 
 

<item> 
<title><![CDATA[Renal Function Outcomes in Kidney Transplant Recipients After Conversion to Everolimus-Based Immunosuppression Regimen with CNI Reduction or Elimination]]></title> 
<link>http://www.mdlinx.com/NephrologyLinx/xml-article.cfm/2982620</link> 
<pubDate>12/18/2009</pubDate> 
<description><![CDATA[<b>Transplantation Proceedings</b>]]></description> 
<guid>http://www.mdlinx.com/NephrologyLinx/xml-article.cfm/2982620</guid>
</item> 
 

<item> 
<title><![CDATA[Low-Dose Dopamine in Kidney Transplantation]]></title> 
<link>http://www.mdlinx.com/NephrologyLinx/xml-article.cfm/2982625</link> 
<pubDate>12/18/2009</pubDate> 
<description><![CDATA[<b>Transplantation Proceedings</b>]]></description> 
<guid>http://www.mdlinx.com/NephrologyLinx/xml-article.cfm/2982625</guid>
</item> 

<item> 
 <title><![CDATA[Visit www.LIPITORHCP.com for more information, free materials, and helpful resources.]]></title> 
 <link>http://WWW.mdlinx.com/tracking.cfm?campaign_id=1172&amp;redirect=http://www.LIPITORHCP.com</link> 
 <pubDate>1/1/2008</pubDate> 
 <description><![CDATA[<b>Sponsored by LIPITOR (atorvastatin calcium)</b>]]></description> 
 <guid>http://www.LIPITORHCP.com</guid> 
</item>
 

<item> 
<title><![CDATA[Iron supplementation in the non-dialysis chronic kidney disease patient: oral or intravenous]]></title> 
<link>http://www.mdlinx.com/NephrologyLinx/xml-article.cfm/2990346</link> 
<pubDate>12/18/2009</pubDate> 
<description><![CDATA[<b>Current Medical Research and Opinion</b>]]></description> 
<guid>http://www.mdlinx.com/NephrologyLinx/xml-article.cfm/2990346</guid>
</item> 
 

<item> 
<title><![CDATA[Optimising intraperitoneal gentamicin dosing in peritoneal dialysis patients with peritonitis (GIPD) study]]></title> 
<link>http://www.mdlinx.com/NephrologyLinx/xml-article.cfm/2988516</link> 
<pubDate>12/18/2009</pubDate> 
<description><![CDATA[<b>BMC Nephrology</b>]]></description> 
<guid>http://www.mdlinx.com/NephrologyLinx/xml-article.cfm/2988516</guid>
</item> 
 

<item> 
<title><![CDATA[Scleroderma Renal Crisis: A Rare but Severe Complication of Systemic Sclerosis]]></title> 
<link>http://www.mdlinx.com/NephrologyLinx/xml-article.cfm/2990067</link> 
<pubDate>12/18/2009</pubDate> 
<description><![CDATA[<b>Clinical Reviews in Allergy and Immunology</b>]]></description> 
<guid>http://www.mdlinx.com/NephrologyLinx/xml-article.cfm/2990067</guid>
</item> 
 

<item> 
<title><![CDATA[Improved 24-Hour Blood Pressure Control With Sirolimus Versus Calcineurin Inhibitor Based Immunosuppression in Renal Transplant Recipients]]></title> 
<link>http://www.mdlinx.com/NephrologyLinx/xml-article.cfm/2982630</link> 
<pubDate>12/18/2009</pubDate> 
<description><![CDATA[<b>Transplantation Proceedings</b>]]></description> 
<guid>http://www.mdlinx.com/NephrologyLinx/xml-article.cfm/2982630</guid>
</item> 
 

<item> 
<title><![CDATA[Late Acute Kidney Transplant Rejection: Clinicopathological Correlates and Response to Corticosteroid Therapy]]></title> 
<link>http://www.mdlinx.com/NephrologyLinx/xml-article.cfm/2982622</link> 
<pubDate>12/18/2009</pubDate> 
<description><![CDATA[<b>Transplantation Proceedings</b>]]></description> 
<guid>http://www.mdlinx.com/NephrologyLinx/xml-article.cfm/2982622</guid>
</item> 
 
 

<item> 
 <title><![CDATA[Visit www.LIPITORHCP.com for more information, free materials, and helpful resources.]]></title> 
 <link>http://WWW.mdlinx.com/tracking.cfm?campaign_id=1172&amp;redirect=http://www.LIPITORHCP.com</link> 
 <pubDate>1/1/2008</pubDate> 
 <description><![CDATA[<b>Sponsored by LIPITOR (atorvastatin calcium)</b>]]></description> 
 <guid>http://www.LIPITORHCP.com</guid> 
</item>
  


</channel> 
</rss>

